期刊
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
卷 16, 期 -, 页码 14-17出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1529-8027.2011.00299.x
关键词
biomarker; CIDP; CMT1; diabetes; diagnosis
Chronic inflammatory demyelinating polyneuropathy ( CIDP) is an autoimmune disease that targets the myelin sheaths in peripheral nerves. Primary demyelination can be detected by electrodiagnostic studies or nerve biopsy, but these do not distinguish between demyelination resulting from CIDP or from non-inflammatory causes such as diabetes or Charcot-Marie-Tooth type I. Consequently, the diagnosis of CIDP in such patients is often missed. Studies are needed to establish electrodiagnostic criteria for CIDP in patients with diabetes, and to identify biomarkers that distinguish between inflammatory and non-inflammatory causes of demyelinating neuropathy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据